GlassScriptPhysician profile
Lisa A Golik
NPI 1992977888
$2,629.45
in general payments reported to CMS, 2019-2025
27 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.10 · 2020: $154 · 2021: $419 · 2022: $222 · 2023: $745 · 2024: $644 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,643 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,642.56 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $366.88 | 2022-2025 | |
| Hologic Sales and Service, LLC | $314.06 | 2019-2025 | Acessa Provu System, Aptima, Omni Hysteroscope |
| Astellas Pharma US INC | $291.97 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $227.17 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $216.05 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $191.29 | 2019-2024 | |
| Myovant Sciences INC. | $129.39 | 2021-2022 | |
| Axonics, INC. | $125.43 | 2023-2024 | Axonics |
| Abbvie INC. | $124.28 | 2020-2025 | |
| Boston Scientific Corporation | $100.26 | 2019-2025 | Axonics |
| Millicent US INC | $84.97 | 2021-2024 | Femring, Intrarosa |
| Agile Therapeutics, INC. | $66.01 | 2022-2024 | Twirla |
| Shield Therapeutics INC | $65.46 | 2024-2025 | |
| Coloplast Corp | $48.56 | 2019-2020 | |
| Evofem Biosciences, INC. | $48.34 | 2020-2025 | Solosec, Phexx, Phexxi |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $30.31 | 2024 | |
| Lupin INC. | $23.72 | 2020 | |
| Genzyme Corporation | $22.18 | 2021 | |
| Ethicon US, LLC | $20.80 | 2025 | Surgicel Nu-Knit, Surgiflo Hemostatic Matrix, Stratafix |
| Allergan, INC. | $19.98 | 2020 | |
| Organon LLC | $18.87 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.12 | 2021 | |
| Tactile Systems Technology INC | $16.91 | 2025 | Nimbl, Flexitouch Plus |
| Dexcom, INC. | $16.60 | 2023 | Dexcom G6 Transmitter |
| Conmed Corporation | $16.12 | 2022 | |
| Medtronic, INC. | $14.26 | 2021 | |
| Meditrina | $11.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Golik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.